PMCB - PharmaCyte Biotech, Inc.

QQQ $ 441.12 $ 0.66 (0.15 %)

DIA $ 392.56 $ 2.45 (0.63 %)

SPY $ 519.17 $ 1.78 (0.34 %)

TLT $ 90.14 $ 0.10 (0.11 %)

GLD $ 216.25 $ 1.44 (0.67 %)

Previous Close

$ 2.16

Open

$ 2.09

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 2.09 - $ 2.09

52 Week Range

$ 1.92 - $ 3.23

Volume

6,203

Average Volume

Market Cap

37.68M

Beta (5Y Monthly)

$ 7.04

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-18-2024	01-31-2024	10-Q
2	12-15-2023	10-31-2023	10-Q
3	09-18-2023	07-31-2023	10-Q
4	07-31-2023	04-30-2023	10-K
5	03-16-2023	01-31-2023	10-Q
6	12-14-2022	10-31-2022	10-Q
7	09-14-2022	07-31-2022	10-Q
8	07-28-2022	04-30-2022	10-K
9	03-15-2022	01-31-2022	10-Q
10	12-14-2021	10-31-2021	10-Q
11	09-14-2021	07-31-2021	10-Q
12	08-10-2021	04-30-2021	10-K
13	03-12-2021	01-31-2021	10-Q
14	12-11-2020	10-31-2020	10-Q
15	09-11-2020	07-31-2020	10-Q
16	08-13-2020	04-30-2020	10-K
17	03-13-2020	01-31-2020	10-Q
18	12-23-2019	10-31-2019	10-Q
19	09-13-2019	07-31-2019	10-Q
20	08-13-2019	04-30-2019	10-K
21	03-14-2019	01-31-2019	10-Q
22	12-14-2018	10-31-2018	10-Q
23	09-12-2018	07-31-2018	10-Q
24	07-20-2018	04-30-2018	10-K
25	03-19-2018	01-31-2018	10-Q
26	12-14-2017	10-31-2017	10-Q
27	09-13-2017	07-31-2017	10-Q
28	07-27-2017	04-30-2017	10-K
29	03-13-2017	01-31-2017	10-Q
30	12-02-2016	10-31-2016	10-Q
31	09-06-2016	07-31-2016	10-Q
32	07-29-2016	04-30-2016	10-K
33	03-08-2016	01-31-2016	10-Q
34	12-10-2015	10-31-2015	10-Q
35	08-25-2015	07-31-2015	10-Q
36	07-29-2015	04-30-2015	10-K
37	03-13-2015	01-31-2015	10-Q
38	12-15-2014	10-31-2014	10-Q
39	09-15-2014	07-31-2014	10-Q
40	08-04-2014	04-30-2014	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

PharmaCyte Biotech Acquires $5M Stake In E...
11/15/2023 13:34:17

New investment marks expansion of corporate strategy to utilize significant cash position to create additional shareholder valu...

Femasys Secures $6.85M Additional Financin...
11/15/2023 12:32:12

PharmaCyte Biotech Provides Corporate Upda...
10/31/2023 13:22:02

Company prepares for comprehensive discussion with FDA to determine appropriate next steps for technology while evaluating addi...

Stocks That Hit 52-Week Lows On Monday
10/02/2023 17:00:10

On Monday, 369 companies set new 52-week lows.

Stocks That Hit 52-Week Lows On Tuesday
09/26/2023 16:04:06

On Tuesday, 386 stocks made new 52-week lows.

Pancreatic Cancer Action Network Urges Adv...
06/14/2023 13:13:30

Federal Funding Increases Fuel Research Progress and Help Improve Patient OutcomesLOS ANGELES, June 14, 2023 /PRNewswire/ -- Th...

12 Health Care Stocks Moving In Thursday's...
05/11/2023 13:06:46

PharmaCyte Biotech Announces Cash Tender O...
05/11/2023 12:35:09

Concurrently, the Company Announces $35 Million Financing of Convertible Preferred Stock at $4.00 per Share PharmaCyte Biotech...

PharmaCyte Biotech Announces $10M Buyback ...
02/02/2023 14:05:32

PharmaCyte Biotech Board Of Directors Anno...
10/07/2022 13:02:48

LAS VEGAS, Oct. 07, 2022 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company&#...

PharmaCyte Biotech Rebukes Iroquois' Comme...
07/28/2022 16:45:51

https://pharmacyte.com/pharmacyte-biotech-rebukes-iroquois-commencement-of-consent-solicitation/

PharmaCyte Biotech Reports Interim Results...
07/19/2022 12:33:29

PharmaCyte Biotech, Inc. (NASDAQ:PMCB), a biotechnology company focused on developing cellular therapies for cancer, diabetes, ...

PharmaCyte Biotech Sees Prelim. FY22 Net L...
07/11/2022 12:35:21

PharmaCyte Biotech Announces Additional Qu...
07/05/2022 12:34:33

PharmaCyte Biotech, Inc. (NASDAQ:PMCB), a biotechnology company focused on developing cellular therapies for cancer, diabetes a...

PharmaCyte Biotech Issues Follow-Up Respon...
06/15/2022 12:36:21

PharmaCyte Biotech, Inc. (NASDAQ:PMCB) (PharmaCyte), a biotechnology company focused on developing cellular therapies for cance...

Iroquois Capital Delivers Open Letter To P...
06/09/2022 13:07:54

roquois Capital Management, LLC (together with its affiliates, "Iroquois"), one of the largest stockholders of PharmaCy...

PharmaCyte Biotech Issues Response To Iroq...
06/08/2022 12:36:58

PharmaCyte Biotech Issues Response to Iroquois Capital Letter and Announces Additional Steps to Increase Shareholder Value Pha...

PharmaCyte Biotech To Implement $10M Share...
06/02/2022 13:01:24

PharmaCyte Biotech to Implement $10-Million Share Repurchase Program PharmaCyte Biotech, Inc. (NASDAQ:PMCB) (PharmaCyte), a bi...

PharmaCyte Biotech Initiates Studies To Co...
05/23/2022 13:03:51

PharmaCyte Biotech, Inc. (NASDAQ:PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabete...

PharmaCyte Biotech ~5% Shareholder, Iroquo...
05/11/2022 13:05:58

Expresses Disappointment in the Board's Failure to Articulate a Plan to Maximize Shareholder Value Amid Prolonged Product D...